PHARMACEUTICALS: FDA Approved New Form of Birth Control in May
Aethlon Medical has been awarded a grant ($3.5 million) for studies in head and neck cancer.
La Jolla Institute for Immunology received a $1 million gift to further its work in COVID-19 research. The GHR Foundation, an independent philanthropy based in Minneapolis, made the gift, announced on Aug. 4.
BIOTECH: Co. Has Two Drugs In Clinical Trials With Plans to Expand
Phamatech will provide on-site sample collection at six school district locations that will then be sent to Phamatech’s laboratory in San Diego for analysis.
BIOTECH: Receives Greenlight on Phase 1/2 of Clinical Trials
Truvian Sciences has received federal emergency approval for its COVID-19 antibodies.
San Diego-based Arcturus Therapeutics Inc. announced its vaccine has been approved to proceed with Phase 1/2 Clinical Trial
San Diego will host the Donate Life Transplant Games 24 months from now. The San Diego County Credit Union Holiday Bowl organization led the successful bid to bring the games to San Diego.
BIOTECH: Artiva Biotherapeutics to Start Clinical Trials This Year
SAFETY: Local Companies Find New Ways to Fight COVID-19
Acadia Pharmaceuticals has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration.
Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies